Table 1. Clinicopathological parameters associated with BCG immunotherapy response.
| BCG responders n = 21 |
BCG non-responders n = 11 |
p value | |
|---|---|---|---|
| Gender, n (%) Male Female |
14 (71.4) 7 (54.5) |
6 (28.6) 5 (45.5) |
0.70* |
| Age, median (range) | 66 (31–82) | 61 (52–71) | 0.68* |
| ≤65 | 8 (61.5) | 5 (38.5) | |
| >65 | 3 (68.4) | 6 (31.6) | |
| Stage, n (%) | 0.14** | ||
| Ta | 2 (33.3) | 4 (44.7) | |
| pT1 | 18 (75) | 6 (25) | |
| Cis*** | 3 (75) | 1 (25) | |
| Grade, n (%) | 0.15* | ||
| Low | 2 (33.3) | 4 (66.7) | |
| High | 19 (73.1) | 7 (26.9) | |
Note: *Fisher’s exact test; **Chi-Square test; ***Including both isolated and concomitant Cis in 2 patients each.